Refine by
Cannabinoid Suppliers & Manufacturers
34 companies found
based inGreensboro, NORTH CAROLINA (USA)
Founded in 1994 by entrepreneur and innovator Phil Shugart and led by him today, Carolina Liquid Chemistries Corp. is a leading provider of chemistry instruments and reagents for use in reference laboratories and clinical laboratories located in ...
based inVancouver, BRITISH COLUMBIA (CANADA)
We’re a leading bioscience company focused on accelerating new and innovative medical solutions for positive impact. XPhyto is striving to have a positive impact on global health. We are creating potentially life-changing solutions through research, ...
based inNorth Perth, AUSTRALIA
Botanix Pharmaceuticals is a clinical stage synthetic cannabinoid pharmaceutical company with a targeted pipeline of dermatology and antimicrobial products. We have attracted a world-class team and significant capital to support the progression of ...
BTX 1801 is initially focused on preventing surgical site infections (SSIs), which are caused by bacteria that get in through surgery incisions and threaten millions of lives every year. Botanix plans to test the capabilities of synthetic ...
based inSan Diego, CALIFORNIA (USA)
SwabTek’s novel test kits set a new standard for narcotics and explosives presumptive field-testing, with technology that is simple, safe, and effective. SwabTek’s dry, paper-based tests provide a safe and simple solution to put field test kits back ...
SwabTek’s Cannabis Test Kit is the answer for testing for the presumptive presence of cannabis in an age where cannabis products are available in any form. Since the kit uses a treated cotton swab, it can be used to test for cannabis residue ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
There are three major parts to the system, enzymes, receptors, and endocannabinoids. The body makes these molecules. Endocannabinoids are similar to cannabinoids, such as CBD. Researchers have isolated two critical endocannabinoids, ...
based inUster, SWITZERLAND
Büchi is a globally leading manufacturer of reactor systems, pilot plants and related services in the field of demanding process requirements in terms of: Corrosion resistance, Pressure resistance, Regulatory, operational and other process related ...
based inNew York, NEW YORK (USA)
We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. Our mission is to improve patient outcomes and save lives. To achieve our mission, we seek to capitalize on ...
We are developing MRI-1867, our licensed rationally designed, orally available, dual-action, hybrid, small molecule that is an inverse agonist of the CB1 receptor, as well as an inhibitor of the iNOS ...
based inColumbia, MARYLAND (USA)
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corporation, headquartered in Kyoto, Japan. Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/industrial, and ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Joint venture collaboration. Early development stage completed. IP application filed. Advisers retained to explore commercial ...
based inNanjing, CHINA
Nanjing Hjchem company provides a solution for every stage of your research processing. We work together various researchers and scientists from laboratory to pilot plant and production scale. Our experienced systems are designed for different ...
based inSantiago de Compostela, SPAIN
We develop and commercialize new chemical tools to spread the use of fluorescence-based methods in drug discovery. Celtarys is a newly created company focused on the development of innovative chemical tools that improve the efficiency of the High ...
Our potent hCB cannabinoids receptors fluorescent ligand shows high affinity for hCB1/CB2 cannabinoids receptor (Ki =44.8 nM and 7.4 nM , respectively in radioligand binding assay). It has been validated in High ...
based inAhmedabad, INDIA
Known as a reliable source of medical marijuana, Shangri-La Dispensaries is the leading medical dispensary Missouri. Ever since the state has legalized the use of medical marijuana, we continuously strive hard to research and produce the best ...
For thousands of years, cannabis has been used for its medical and psychedelic properties. Chinese emperor Shen Nung was the first to list medical uses for the plant by adding it to his pharmacopeia in 2800 BCE. But, what is cannabis? Cannabis, as ...
based inDoylestown, PENNSYLVANIA (USA)
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from our proprietary socially responsible pain management therapeutics to treat patients with a ...
based inJupiter, FLORIDA (USA)
Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and ...
Reducing the cost of recombinant protein production requires a highly productive, low-cost expression system with commercial scale flexibility. We are actively applying our proprietary Dapibus™ platform and other technologies to address this ...
based inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
It is involved in regulating several pathways linked to energy intake, reserves and overall expenditure. To do so, the cannabinoid-1 receptor (CB1) may be activated and deactivated such that it impacts many metabolic pathways ...
based inDoylestown, PENNSYLVANIA (USA)
Diverse Biotech, Inc is an innovative drug-discovery & biopharmaceutical research company committed to discovering and developing novel therapies from its proprietary conjugate drug synthesis Platform. The company originated from oncologists adding ...
based inDavis, CALIFORNIA (USA)
Arcadia Biosciences is a global leader in designing crops to meet the needs of a hungry population in a resource restricted world. Our innovations bring new value to formerly commoditized crops through functional nutritional benefits like added ...
based inDundee, UNITED KINGDOM
James Hutton Limited provides research and consultancy services for several different sectors including agrifood, oil and gas, environmental and water. James Hutton Limited analytical services are delivered by world leading scientists. These are ...
Our experience of compound and contaminant analyses, including oils, makes us the perfect choice for the analysis of cannabidiol, cannabinoids and CBD ...
based inCambridge, UNITED KINGDOM
GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...
Schizophrenia is a chronic disease that manifests through disturbances of perception, thought, cognition, emotion, motivation and motor activity. Over a lifetime, about 1% of the population will develop ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
RSL3 ((1S,3R)-RSL3) is an inhibitor of glutathione peroxidase 4 (GPX4) (ferroptosis activator), reduces the expression of GPX4 protein, and induces ferroptotic death of head and neck cancer cell. RSL3 increases the expression of p62 and Nrf2 and ...